LOADING
Comparing Johnson & Johnson (JNJ) and Coca-Cola Company (KO) across the Health Care and Consumer Staples sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | JNJ | KO |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $611.1B | $357.5B |
| P/E Ratio | 29.4 | 26.5 |
| Forward P/E | 22.3 | 25.9 |
| PEG Ratio | 4.95 | 4.32 |
| EPS | $8.64 | $3.13 |
| Revenue Growth (YoY) | 9.9% | 12.1% |
| Profit Margin | 21.8% | 27.8% |
| Return on Equity | 26.4% | 43.4% |
| Dividend Yield | 2.02% | 2.45% |
| Beta | 0.23 | 0.35 |
| 52-Week High | $269.43 | $85.68 |
| 52-Week Low | $158.33 | $64.04 |
| Volume | -- | -- |
Johnson & Johnson is the larger company by market capitalization. Coca-Cola Company trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Coca-Cola Company offers a higher dividend yield for income investors. Coca-Cola Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.